|
|
||||||||
European Journal of Cardio-Thoracic Surgery, Vol 9, 701-706, Copyright © 1995 by European Association for Cardio-thoracic Surgery
MG Pala, G Paolini, R Paroni, E De Veechi, C Gallorini, PL Stefano, G Di Credico, M Zuccari, L Galli and V Agape
We tested the hypothesis that controlled reperfusion with leukocyte-
depleted blood could improve myocardial protection by reducing the
oxidative stress in patients undergoing myocardial revascularization.
Thirty-four patients receiving antegrade/retrograde blood cardioplegia were
divided into: group A: 11 patients with ejection fractions (EF) less than
35%, treated with leukocyte-depleted controlled blood reperfusion, group B:
11 patients with EF less than 35% in whom no leukocyte depletion was
performed, group C: 6 patients with EF more than 45% treated as group A and
group D: 6 patients with EF more than 45% without leukocyte depletion. To
asses the oxidative stress, we evaluated total, total oxidized (GSSX), and
reduced glutathione (GSH) in coronary sinus plasma, immediately before
cross-clamping the aorta (T0), and at 0 (T1), 15 (T2) and 30 (T3) min after
unclamping it. In groups A and B a significant shift towards oxidation of
redox status of glutathione (GSH/GSSX) at T1 vs T0 was observed.
Glutathione redox ratio remained low in group B while in group A it
returned to the basal value at T2 with a significant difference from group
B at T2 and T3. No differences were observed between groups C and D. In
conclusion, our data show that leukocyte-depleted reperfusion can afford a
better myocardial protection in patients with left ventricular dysfunction,
while it seems unnecessary in patients with normal EF.
ARTICLES
Myocardial protection with and without leukocyte depletion: a comparative study on the oxidative stress
Institute for Cardiovascular and Respiratory Diseases, University of Milan, Italy.
This article has been cited by other articles:
![]() |
O. Warren, C. Alexiou, R. Massey, D. Leff, S. Purkayastha, J. Kinross, A. Darzi, and T. Athanasiou The effects of various leukocyte filtration strategies in cardiac surgery Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 665 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Salamonsen, J. Anderson, M. Anderson, M. Bailey, G. Magrin, and F. Rosenfeldt Total Leukocyte Control for Elective Coronary Bypass Surgery Does Not Improve Short-Term Outcome Ann. Thorac. Surg., June 1, 2005; 79(6): 2032 - 2038. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Martin, M. Krause, C. Benk, G. Lutter, M. Siegenthaler, and F. Beyersdorf Blood cardioplegia filtration Perfusion, January 1, 2003; 18(1_suppl): 75 - 80. [Abstract] [PDF] |
||||
![]() |
K. Yasunari, K. Maeda, M. Nakamura, and J. Yoshikawa Oxidative Stress in Leukocytes Is a Possible Link Between Blood Pressure, Blood Glucose, and C-Reacting Protein Hypertension, March 1, 2002; 39(3): 777 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Roth, B. Kraus, T. Scheffold, O. Reuthebuch, W. P. Klovekorn, and E. P. Bauer The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: A randomized, double-blind study J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 642 - 650. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |